CD16/CD32 Monoclonal Antibody (93), eBioscience
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0451898-V3
- Awardee
- LIFE TECHNOLOGIES CORPORATION
- Contracting organization
- University of Virginia
- Cumulative value
- $223.50
About this award
The University of Virginia awarded contract A207_PO-0451898-V3 to Life Technologies Corporation on August 1, 2026. The contract encompasses the procurement of CD16/CD32 Monoclonal Antibody (eBioscience brand) in a quantity of 223 units, with a total contract value of $223. The monoclonal antibodies are to be delivered to the buyer, with the contracting organization serving as the performance location within Virginia.
The line item specification calls for 223 individual units of CD16/CD32 Monoclonal Antibody at a unit price of $1 per unit. This contract represents a research-grade immunological reagent procurement, consistent with the University of Virginia's scientific and medical research requirements. No additional contract periods or renewal options are evident from the available documentation.
Line items
| Item | Total |
|---|---|
| CD16/CD32 Monoclonal Antibody (93), eBioscience | $223.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0451898-V3?
Contract A207_PO-0451898-V3 was awarded to LIFE TECHNOLOGIES CORPORATION by University of Virginia on August 1, 2026.
How much is contract A207_PO-0451898-V3 worth?
Its cumulative value is $223.50.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award